Literature DB >> 7960418

Screening for psychiatric morbidity in a medical outpatient clinic for HIV infection: the need for a psychiatric presence.

C G Lyketsos1, A Hanson, M Fishman, P R McHugh, G J Treisman.   

Abstract

OBJECTIVE: To ascertain the prevalence and type of psychiatric morbidity present in HIV infected patients presenting for the first time to a specialty HIV medical clinic. Also, to develop a way of screening for psychiatric cases in this setting using established self-report questionnaires.
METHOD: Fifty patients who presented consecutively for medical care at the Johns Hopkins Hospital General HIV Clinic participated in this study. These patients were first screened using the General Health Questionnaire and the Beck Depression Inventory and subsequently underwent a comprehensive neuropsychiatric evaluation.
RESULTS: Fifty-four percent were found to suffer from a psychiatric disorder with an additional 22 percent from an active substance use disorder. These rates are one-and-one-half to two times higher than those reported from other medical clinics. The GHQ and BDI used together as screens could identify psychiatric "cases" with a sensitivity of 81 percent and a specificity of 61 percent, an efficacy similar to that found in other clinics.
CONCLUSIONS: Given the high prevalence of psychiatric disorders in HIV infected patients presenting for medical care, screening, evaluating, and treating for these disorders is crucial and should be pursued systematically. This is best done through the presence of a psychiatric team within HIV medical clinics rather than in affiliation with such clinics.

Entities:  

Mesh:

Year:  1994        PMID: 7960418     DOI: 10.2190/URTC-AQVJ-N9KG-0RL4

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  23 in total

Review 1.  Neuropsychiatric complications of aging with HIV.

Authors:  Crystal C Watkins; Glenn J Treisman
Journal:  J Neurovirol       Date:  2012-05-30       Impact factor: 2.643

Review 2.  Drug treatment of depression in HIV-positive patients : safety considerations.

Authors:  Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 3.  Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.

Authors:  Crystal C Watkins; Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

4.  Psychotropic medication use in human immunodeficiency virus-infected youth receiving treatment at a single institution.

Authors:  Lori Wiener; Haven Battles; Celia Ryder; Maryland Pao
Journal:  J Child Adolesc Psychopharmacol       Date:  2006-12       Impact factor: 2.576

5.  Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States.

Authors:  Bryan Hartzler; Julia C Dombrowski; Heidi M Crane; Joseph J Eron; Elvin H Geng; W Christopher Mathews; Kenneth H Mayer; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Benigno Rodriguez; Dennis M Donovan
Journal:  AIDS Behav       Date:  2017-04

6.  Psychological distress, substance use, and adjustment among parents living with HIV.

Authors:  Risë B Goldstein; Mallory O Johnson; Mary Jane Rotheram-Borus; Sheri B Kirshenbaum; Rogério M Pinto; Lauren Kittel; Willo Pequegnat; Joanne D Mickalian; Lance S Weinhardt; Jeffrey A Kelly; Marguerita Lightfoot
Journal:  J Am Board Fam Pract       Date:  2005 Sep-Oct

7.  Human immunodeficiency virus and depression in primary care: a clinical review.

Authors:  Tiziano Colibazzi; Teresa T Hsu; William S Gilmer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

8.  Participants' perspectives on cognitive-behavioral therapy for adherence and depression in HIV.

Authors:  Carla Berg; Sudha Raminani; Joseph Greer; Meaghan Harwood; Steven Safren
Journal:  Psychother Res       Date:  2008-05

9.  A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals.

Authors:  Steven A Safren; Conall O'Cleirigh; Judy Y Tan; Sudha R Raminani; Laura C Reilly; Michael W Otto; Kenneth H Mayer
Journal:  Health Psychol       Date:  2009-01       Impact factor: 4.267

10.  The impact of combination antiretroviral therapy and its interruption on anxiety, stress, depression and quality of life in Thai patients.

Authors:  Reto Nüesch; Angèle Gayet-Ageron; Ploenchan Chetchotisakd; Wisit Prasithsirikul; Sasisopin Kiertiburanakul; Warangkana Munsakul; Phitsanu Raksakulkarn; Somboon Tansuphasawasdikul; Sineenart Chautrakarn; Kiat Ruxrungtham; Bernard Hirschel; Jintanat Anaworanich
Journal:  Open AIDS J       Date:  2009-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.